178 filings
Page 5 of 9
8-K
8gplu2sfmimzwpc8 57
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
8-K
27tvsklpwbj
20 Nov 19
Other Events
7:05am
8-K
r51h 6rorbnxcwzl793
8 Nov 19
CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
2:33pm
8-K
2a1mceihvn6gnzs y1of
7 Nov 19
Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
2edagw u4iuha
3 Oct 19
Other Events
7:15am
8-K
ucmrf4bz4be3
27 Sep 19
Other Events
10:15am
8-K
j5tltyq9iufcq8ne6t
13 Sep 19
Departure of Directors or Certain Officers
4:05pm
8-K
anfazo w9
12 Aug 19
Other Events
7:05am
8-K
421t7gu fo
8 Aug 19
Aravive Announces Executive Management Transition Plan
5:06pm
8-K
ehd 8z9dl
7 Aug 19
Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:10pm
8-K
fcxwc twahi54f
31 Jul 19
Aravive Reports Preliminary Results ofAVB-500 from the First Cohort of the Phase 1b/Phase 2 Recurrent Platinum Resistant Ovarian Cancer Trial
7:15am
8-K
xoo md81q9t4
11 Jul 19
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:32am
8-K
w6gaik vkwa
8 Jul 19
Other Events
7:16am
8-K
z7w4ras0ayzzr51kx
31 May 19
Termination of a Material Definitive Agreement
4:16pm
8-K
hm8io4wrf ag
8 May 19
Aravive Reports First Quarter 2019 Financial Results and Provides Recent Corporate Updates
4:15pm
8-K
zzxrj9z
11 Apr 19
Departure of Directors or Certain Officers
4:29pm
8-K
2ju aow1a5re
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
8-K
tz04ufb
7 Mar 19
Results of Operations and Financial Condition
4:16pm
8-K
1pv7xk 9w3bgb3
6 Mar 19
Departure of Directors or Certain Officers
6:05am
8-K
a3ruem
12 Feb 19
Departure of Directors or Certain Officers
4:20pm